Study details how COVID outbreaks led to lasting staff loss in nursing homes — and poses solutions … McKnight’s podcast: Why LTC providers must embrace more palliative care … Thursday’s CDC...
AARP: Nursing home residents in West bearing brunt of COVID infection uptick
By
Alicia Lasek
Aug 22, 2022
Nursing home deaths and cases continued to rise in July for the third consecutive month, according to the latest analysis of federal data. Weekly upticks hint that the increases have not yet peaked.
Symptomless COVID infections found in almost half of US adults, CDC says
By
Alicia Lasek
Dec 05, 2022
Approximately 44% of US adults were “possibly asymptomatically infected,” between August 2021 and May 2022, blood serum evidence shows.
Study finds 57 percent of previously healthy COVID survivors have lasting cardiac issues
By
Alicia Lasek
Sep 19, 2022
Cardiac symptoms may linger for at least a year in some patients who recover from mild cases of COVID-19, researchers have found.
Use of deauthorized COVID antibody treatments widespread in early 2022: study
By
Alicia Lasek
Sep 01, 2022
Some U.S. clinicians continued to rely on two monoclonal antibody treatments for COVID after they were deauthorized by the FDA, researchers report.
CDC: More nursing homes now can obtain, provide single-dose COVID vaccines
By
Alicia Lasek
Dec 20, 2022
Nursing homes that are not already enrolled as full providers in the CDC’s COVID-19 Vaccination Program now can apply to provide shots directly to residents and staff.
High blood pressure plus COVID doubles risk of hospital stay: study
By
Alicia Lasek (f3)
Jul 25, 2022
Even after three COVID-19 vaccine doses, high blood pressure more than doubles the risk for hospitalization with an omicron variant infection, researchers report.
Slow recovery from illness may reflect pandemic-related stress: study
By
Alicia Lasek
Dec 07, 2022
The pandemic itself, including related stress, may be contributing to slow recoveries after COVID and non-COVID illnesses alike, investigators say.
Large EHR study confirms Paxlovid works best within 5-day time window
By
Alicia Lasek
Mar 20, 2023
Protection against severe outcomes soared to 80% when the drug was dispensed within five days of symptom onset, compared with 54% efficacy outside that time frame, investigators found.
Post-COVID complaints continue to affect recovered healthcare workers, study finds
By
Alicia Lasek (f3)
Jul 21, 2022
Pulmonary tests may be useful in the decision to return to work, and should be received regularly after workers with lingering issues are back on the job, investigators say.